Expert Review of Neurotherapeutics

Article	Citations
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	45
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	38
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	34
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	33
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	30
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	29
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	29
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	28
The relevance of cortical thickness in migraine sufferers and implications to therapy	26
Where Art Thou O treatment for diabetic neuropathy: the sequel	25
Advances in the treatment and management of frontotemporal dementia	25
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	24
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	23
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases	23
Outcomes measures in idiopathic intracranial hypertension	23
The latest developments with internet-based psychological treatments for depression	22
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	21
Updated review on the link between cortical spreading depression and headache disorders	20
Why is ADHD so difficult to diagnose in older adults?	20
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	20
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	19
Emerging role of artificial intelligence in stroke imaging	19
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	19
Recent advancements in tension-type headache: a narrative review	19
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	19

Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	19
Correction	18
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	18
Spinal automaticity of movement control and its role in recovering function after spinal injury	17
Advances in the early diagnosis of amyotrophic lateral sclerosis	17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	17
Hesitancies in primary headaches treatments	17
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	17
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	17
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	16
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	16
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	16
Mindfulness as a therapeutic option for obsessive-compulsive disorder	16
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	16
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	16
The differential diagnosis of autism spectrum disorder in adults	15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	15
Illuminating the way: the role of bright light therapy in the treatment of depression	15
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	14
Considerations for hormonal therapy in migraine patients: a critical review of current practice	14
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	14
Food for thought: the emerging role of a ketogenic diet in Alzheimer’s disease management	13
Multimodal approaches to the treatment of personality disorder	13
Virtual reality technology in the treatment of anxiety – progress and future challenges	13
Cross-national reflections on medicinal cannabis and depression	13
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	13
Current use of neurotoxins for alleviating symptoms of cervical dystonia	13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	13
Long-term outcomes in refractory status epilepticus	12
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	12
Frontotemporal dementia. How to deal with its diagnostic complexity?	12
A novel treatment option for intrajejunal levodopa administration	12
Advancements in neuroactive peptides in seizures	12
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	12
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis	12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	12
Considering hearing loss as a modifiable risk factor for dementia	12
Updated review of rescue treatments for seizure clusters and prolonged seizures	11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	11
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	11
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	11
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	11
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	11
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	11
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	11
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	10
Could self-reporting sleep duration become an important tool in the prediction of dementia?	10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	10
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	10

Developments in targeting calcitonin gene-related peptide	10
Bipolar disorder staging and the impact it has on its management: an update	10
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	10
Therapeutic issues in Guillain–Barré syndrome	10
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	10
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	10
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	10
Long-term central nervous system (CNS) consequences of COVID-19 in children	9
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	9
Rethinking the role of trazodone in the different depressive dimensions	9
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	9
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	9
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	8
Tobacco use disorder and depression: emerging strategies and recommendations:	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Learnings in developmental and epileptic encephalopathies: what do we know?	8
The challenges and opportunities related to the therapeutic use of music in psychiatry	8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	8
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	8
Meniere disease subtyping: the direction of diagnosis and treatment in the future	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	8
Contemporary diagnosis and treatment of conduct disorder in youth	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	7
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	7
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	7
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	7
Sydenham’s chorea: from pathophysiology to therapeutics	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	7
A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children	7
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	7
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	7
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	7
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	7
An update on pharmacotherapy for trigeminal neuralgia	7
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	7
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
Current and emerging therapies for autoimmune encephalitis	6
Exploring the role of botulinum toxin in critical care	6
Is postpartum depression a clinically useful concept?	6
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance	6
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials	6
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	6
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	6
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
What impact can brain stimulation interventions have on borderline personality disorder?	6
Letter to the editor: reflections on the future of medical cannabis research for depression	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
When is pharmacological intervention recommended for adults with social anxiety disorder?	6
Pharmacological options for narcolepsy: are they the way forward?	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
Postoperative pain: a review of emerging therapeutic options	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
Insights into headache 2022	5
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	5
Is it possible to prevent relapse in panic disorder?	5
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	5
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	5
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	5
Pain in cervical dystonia: mechanisms, assessment and treatment	5
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Central vestibular dysfunction: don’t forget vestibular rehabilitation	5
Challenges in the treatment of dysthymia: a narrative review	5

Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	5
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	5
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	5
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	5
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	5
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	5
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	5
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	5
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	5
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	5
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Can regular physical exercise be a treatment for panic disorder? A systematic review	4
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	4
Real world considerations for newly approved CGRP receptor antagonists in migraine care	4
Rethinking the medication management of major depression	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Current perspectives on the diagnosis and management of acute transverse myelitis	4
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	4
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	4
Essential tremor - drug treatments present and future	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
Novel and emerging therapeutics for genetic epilepsies	4
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
What is the role of placebo in neurotherapeutics?	4
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	4
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	4
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice	4
Are ketamine and its enantiomers the answer to treatment-refractory depression?	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	3
Overcoming clinical challenges of refractory neuropathic pain	3
Current and emerging treatment options for Angelman syndrome	3
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	3
Withdrawal of antiseizure medications – for whom, when, and how?	3
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	3
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	3
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	3
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	3
The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications	3
Managing cognitive impairment in Parkinson’s disease: an update of the literature	3
Nanomaterials in neuromodulation: what is the potential?	3
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	3
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	3
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	3
Risk factors and disease associations in people living with idiopathic intracranial hypertension	3
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	3
Novel techniques for early diagnosis and monitoring of Alzheimer’s disease	3
Suicidality and antiepileptic drugs in people with epilepsy: an update	3
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy	3
Status epilepticus in pregnancy: a literature review and a protocol proposal	3
Tumefactive demyelination: updated perspectives on diagnosis and management	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	3
Can pharmacotherapy help to reduce trichotillomania?	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials	3
Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
Current perspectives on the clinical management of cryptogenic stroke	3